Status:
ENROLLING_BY_INVITATION
Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Substance Use Disorders (SUDs)
Eligibility:
All Genders
18-99 years
Brief Summary
Background: A Timeline Follow-Back (TLFB) is a tool that helps researchers track how much of a substance a person uses. Different versions of the tool are used to track the use of alcohol, cigarettes...
Detailed Description
Study Description: Observational, on-site study for the purpose of instrument development. Currently used assessments of recent opioid use do not reflect the current market for street opioids. This p...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- To be eligible to participate in this study, an individual must meet the following criteria:
- Age 18 years or older
- Past 30-day use of an opioid obtained in a nonmedical context (i.e., not from a pharmacy or in a healthcare setting)
- Able to understand and communicate in written and spoken English.
- Justification: Initial development of the OpiTLFB requires strong, unmediated communication between the study team and the participants. Further development and modification for non-English-speaking interviewees is best undertaken as a separate project when the OpiTLFB is ready for use.
- Ability of subject to understand and the willingness to sign a written informed consent document.
- EXCLUSION CRITERIA:
- 1\. Any medical, psychiatric, or social conditions that the investigators believe would make participation in this protocol not in the best interest of the participant.
Exclusion
Key Trial Info
Start Date :
January 14 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06995885
Start Date
January 14 2026
End Date
May 31 2027
Last Update
January 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute on Drug Abuse
Baltimore, Maryland, United States, 21224